Selective upregulation of β1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 3, 2006, Pages 441-450

  Milting, Hendrik ^a   Scholz, Christian ^c   Arusoglu, Latif ^a   Freitag, Meike ^b   Cebulla, Ramona ^a   Jaquet, Kornelia ^b   Körfer, Reiner ^a   v Lewinski, Dirk ^c   Kassner, Astrid ^a   Brodde, Otto Erich ^d   Kögler, Harald ^c   El Banayosy, Aly ^a   Pieske, Burkert ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Beta receptor; Heart failure; Reverse remodeling; Troponin I; Ventricular assist device

Indexed keywords

ANTIBODY; BETA 1 ADRENERGIC RECEPTOR; MESSENGER RNA; TROPONIN I;

ADRENERGIC ACTIVITY; ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; HUMAN TISSUE; LIGAND BINDING; MALE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DENSITY; RECEPTOR UPREGULATION; RNA ANALYSIS; SIGNAL TRANSDUCTION; CHEMISTRY; CONGESTIVE HEART FAILURE; GENE EXPRESSION REGULATION; HEART DISEASE; HEART VENTRICLE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; UPREGULATION;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION; HEART DISEASES; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLATION; RECEPTORS, ADRENERGIC, BETA-1; SIGNAL TRANSDUCTION; TROPONIN I; UP-REGULATION;

EID: 33748436054     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.04.010     Document Type: Article

References (43)

1. Zerkowski H.R., Broede A., Kunde K., Hillemann S., Schafer E., Vogelsang M., et al. Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 347 (1993) 347-352
2. Bristow M.R., Ginsburg R., Minobe W., Cubicciotti R.S., Sageman W.S., Lurie K., et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307 (1982) 205-211
3. Brodde O.-E. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43 (1991) 203-242
4. Ungerer M., Böhm M., Elce J.S., Erdmann E., and Lohse M.J. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87 (1993) 454-463
5. Zhu W.Z., Zheng M., Koch W.J., Lefkowitz R.J., Kobilka B.K., and Xiao R.P. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A 98 (2001) 1607-1612
6. Daaka Y., Luttrell L.M., and Lefkowitz R.J. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390 (1997) 88-91
7. Steinberg S.F. The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85 (1999) 1101-1111
8. Zaugg M., Xu W., Lucchinetti E., Shafiq S.A., Jamali N.Z., and Siddiqui M.A. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102 (2000) 344-350
9. Wattanapermpool J., Guo X., and Solaro R.J. The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated. J Mol Cell Cardiol 27 (1995) 1383-1391
10. Brodde O.-E., Zerkowski H.R., Doetsch N., Motomura S., Khamssi M., and Michel M.C. Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol 14 (1989) 323-331
11. Steinfath M., Geertz B., Schmitz W., Scholz H., Haverich A., Breil I., et al. Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases. Naunyn-Schmiedeberg's Arch Pharmacol 343 (1991) 217-220
12. Brodde O.-E., Vogelsang M., Broede A., Michel-Reher M., Beisenbusch-Schafer E., Hakim K., et al. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 31 (1998) 585-594
13. van der Velden J., Papp Z., Zaremba R., Boontje N.M., de Jong J.W., Owen V.J., et al. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 57 (2003) 37-47
14. Pieske B. Reverse remodeling in heart failure-Fact or fiction?. Eur Heart J 6 (2004) D66-D78
15. Dipla K., Mattiello J.A., Jeevanandam V., Houser S.R., and Margulies K.B. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 97 (1998) 2316-2322
16. Ogletree-Hughes M.L., Stull L.B., Sweet W.E., Smedira N.G., McCarthy P.M., and Moravec C.S. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 104 (2001) 881-886
17. Klotz S., Barbone A., Reiken S., Holmes J.W., Naka Y., Oz M.C., Marks A.R., and Burkhoff D. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol 45 (2005) 668-676
18. Tevaearai H.T., Eckhart A.D., Walton G.B., Keys J.R., Wilson K., and Koch W.J. Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts. Circulation 106 (2002) 124-129
19. Hon J.K., and Yacoub M.H. Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg 75 (2003) S36-S41
20. Brodde O.-E., Zerkowski H.R., Schranz D., Sitz B.A., Reher M.M., Beisenbusch S.E., et al. Age-dependent changes in the beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in human right atrium. J Cardiovasc Pharmacol 26 (1995) 20-26
21. Katrukha A.G., Bereznikova A.V., Esakova T.V., Pettersson K., Lovgren T., Severina M.E., et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 43 (1997) 1379-1385
22. Filatov V.L., Katrukha A.G., Bereznikova A.V., Esakova T.V., Bulargina T.V., Kolosova O.V., et al. Epitope mapping of anti-troponin I monoclonal antibodies. Biochem Mol Biol Int 45 (1998) 1179-1187
23. Deng Y., Schmidtmann A., Kruse S., Filatov V., Heilmeyer Jr. L.M., Jaquet K., et al. Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways. J Mol Cell Cardiol 35 (2003) 1365-1374
24. Lowes B.D., Gilbert E.M., Abraham W.T., Minobe W.A., Larrabee P., Ferguson D., et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 346 (2002) 1357-1365
25. Ardelt P., Dorka P., Jaquet K., HeilmeyerJr L.M., Körtke H., Körfer R., et al. Microanalysis and distribution of cardiac troponin I phospho species in heart areas. Biol Chem 379 (1998) 341-347
26. El-Banayosy A., Deng M., Loisance D.Y., Vetter H., Gronda E., Loebe M., et al. The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study. Eur J Cardio-thorac Surg 15 (1999) 835-841
27. Milting H., El-Banayosy A., Kassner A., Fey O., Sarnowski P., Arusoglu L., et al. The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types. J Heart Lung Transplant 20 (2001) 949-955
28. Müller J., Wallukat G., Weng Y.-G., Dandel M., Spiegelsberger S., Semrau S., et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 96 (1997) 542-549
29. El-Banayosy A., Arusoglu L., Kizner L., Fey O., Sarnowski P., Morshuis M., et al. Hemodynamic exercise testing reveals a low incidence of myocardial recovery in LVAD patients. J Heart Lung Transplant 20 (2001) 209-210
30. Mancini D.M., Beniaminovitz A., Levin H., Catanese K., Flannery M., and DiTullio M. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98 (1998) 2383-2389
31. Ihl-Vahl R., Eschenhagen T., Kubler W., Marquetant R., Nose M., Schmitz W., et al. Differential regulation of mRNA specific for beta 1- and beta 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods. J Mol Cell Cardiol 28 (1996) 1-10
32. Michel M.C., Pingsmann A., Beckeringh J.J., Zerkowski H.R., Doetsch N., and Brodde O.-E. Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment. Br J Pharmacol 94 (1988) 685-692
33. Bohm M., Beuckelmann D., Brown L., Feiler G., Lorenz B., Nabauer M., et al. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J 9 (1988) 844-852
34. Conne B., Stutz A., and Vassalli J.D. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology?. Nat Med 6 (2000) 637-641
35. Bevilacqua A., Ceriani M.C., Capaccioli S., and Nicolin A. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 195 (2003) 356-372
36. Blaxall B.C., and Port J.D. Adrenergic receptor protocols. In: Machida C. (Ed). Adrenergic receptor protocols (2000), Humana Press Inc., Totowa, New Jersey 453-465
37. Mitchusson K.D., Blaxall B.C., Pende A., and Port J.D. Agonist-mediated destabilization of human beta1-adrenergic receptor mRNA: role of the 3′ untranslated translated region. Biochem Biophys Res Commun 252 (1998) 357-362
38. Hadcock J.R., Wang H.Y., and Malbon C.C. Agonist-induced destabilization of beta-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors. J Biol Chem 264 (1989) 19928-19933
39. Danner S., Frank M., and Lohse M.J. Agonist regulation of human beta2-adrenergic receptor mRNA stability occurs via a specific AU-rich element. J Biol Chem 273 (1998) 3223-3229
40. Bartel S., Stein B., Eschenhagen T., Mende U., Neumann J., Schmitz W., et al. Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts. Mol Cell Biochem 157 (1996) 171-179
41. El-Armouche A., Pamminger T., Ditz D., Zolk O., and Eschenhagen T. Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc Res 61 (2004) 87-93
42. James K.B., McCarthy P.M., Thomas J.D., Vargo R., Hobbs R.E., Sapp S., et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 92 (1995) II191-II195
43. Milting H., Jacob M., Kassner A., Heimann P., Mannherz H.G., Becker G., et al. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling. J Heart Lung Transplant 23 (2004) 396-404